Related Experiment Video
Updated: Jul 1, 2026
09:43
Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
Prostatic tumor stroma: a key player in cancer progression
1Centre for Urological Research, Monash Institute of Medical Research, Monash University, Victoria, Australia. renea.taylor@med.monash.edu.au
Current Cancer Drug Targets
|September 11, 2008
Summary
Prostate cancer stem cells rely on the tumor stroma for growth and survival. Targeting this microenvironment is crucial for developing new prostate cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Prostate Cancer Research
Background:
- Prostatic epithelial stem cells maintain normal and malignant tissues.
- The stromal microenvironment is essential for prostate development and homeostasis.
- Tumor stroma plays a critical role in prostate cancer progression, invasion, and metastasis.
Purpose of the Study:
- To elucidate the role of the prostatic tumor stroma in prostate cancer.
- To understand the interactions between cancer stem cells and their microenvironment.
- To explore the rationale and challenges of targeting the tumor stroma for prostate cancer therapy.
Main Methods:
- Review of existing literature on prostate cancer stem cells and tumor microenvironment.
- Analysis of the interplay between epithelial cells and stromal components.
- Discussion of therapeutic strategies targeting the tumor stroma.
Main Results:
- Prostatic stroma provides a niche supporting cancer stem cell self-renewal and differentiation.
- The tumor microenvironment significantly influences cancer cell growth, survival, and metastasis.
- Understanding these interactions is key to developing novel treatments.
Conclusions:
- Targeting the prostatic tumor stroma presents a promising therapeutic avenue for prostate cancer.
- Further research into the cancer stem cell-stroma interactions is necessary.
- Overcoming challenges in stromal targeting could lead to effective prostate cancer treatments.
More Related Videos
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...